Aeonvital is a biomedical research company in Beijing, with a primary focus on research and development toward cancer immunotherapy. Through close collaboration with scientists from China, Australia and United States and in partnership with several biotechnology enterprises, Aeonvital currently develops various products related to tumor-infiltrating lymphocytes, natural killer cells, as well as therapeutic cancer vaccines.

At Aeonvital, our core executive team has broad experiences with top-tier pharmaceutical companies and academic institutions. To turn our vision into collective actions, we follow a key principle, i.e., a successful therapeutic product must be efficacious, safe and affordable for the right patient population, preferably with a lasting impact on human health.